. NPT088 reduces both amyloid-β and tau pathologies in transgenic mice. Alzheimers Dement (N Y). 2016 Sep;2(3):141-155. Epub 2016 Jul 14 PubMed.


Please login to recommend the paper.


No Available Comments

Make a Comment

To make a comment you must login or register.

This paper appears in the following:


  1. At CTAD, Tau PET Emerges as Favored Outcome Biomarker for Trials